PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 169.00
+1.00 (0.60%)
Aug 27, 2026, 2:39 PM JST
PRISM BioLab Co.,LTD Income Statement
Financials in millions JPY. Fiscal year is October - September.
Millions JPY. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| 737.27 | 677.33 | 305.62 | 112.93 | 554 | |
Revenue Growth | 84.85% | 121.63% | 170.64% | -79.62% | - |
Cost of Revenue | 361.65 | 407.57 | 145.08 | 32.62 | 19 |
Gross Profit | 375.62 | 269.76 | 160.54 | 80.31 | 535 |
Selling, General & Admin | 1,226 | 1,044 | 942.93 | 238.08 | 468 |
Research & Development | - | - | - | 338.73 | - |
Operating Expenses | 1,226 | 1,044 | 942.93 | 577.17 | 468 |
Operating Income | -850.75 | -774.45 | -782.39 | -496.87 | 67 |
Interest & Investment Income | 13.67 | 5.3 | 0.36 | 0.02 | - |
Currency Exchange Gain (Loss) | 28.3 | 21.5 | -15.54 | -0.77 | 13 |
Other Non Operating Income (Expenses) | -1.06 | -0.65 | -34.1 | 0.07 | -3 |
EBT Excluding Unusual Items | -809.85 | -748.3 | -831.67 | -497.55 | 77 |
Gain (Loss) on Sale of Assets | -0.1 | - | 0.25 | -0 | -4 |
Asset Writedown | -63.06 | -82.98 | -216.78 | -28.15 | - |
Pretax Income | -873.01 | -831.28 | -1,048 | -525.7 | 73 |
Income Tax Expense | 2.42 | 2.42 | 1.31 | 1.21 | 1 |
Net Income | -875.43 | -833.7 | -1,050 | -526.91 | 72 |
Net Income to Common | -875.43 | -833.7 | -1,050 | -526.91 | 72 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 37 | 37 | 31 | 28 | 27 |
Shares Outstanding (Diluted) | 37 | 37 | 31 | 28 | 27 |
Shares Change | 1.69% | 16.70% | 13.40% | 0.94% | - |
EPS (Basic) | -23.73 | -22.82 | -33.53 | -19.09 | 2.63 |
EPS (Diluted) | -23.73 | -22.82 | -33.53 | -19.09 | 2.63 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Free Cash Flow | - | -1,533 | -55.64 | -548.4 | - |
Free Cash Flow Per Share | - | -41.97 | -1.78 | -19.87 | - |
Gross Margin | 50.95% | 39.83% | 52.53% | 71.11% | 96.57% |
Operating Margin | -115.39% | -114.34% | -256.00% | -439.99% | 12.09% |
Profit Margin | -118.74% | -123.09% | -343.41% | -466.60% | 13.00% |
Free Cash Flow Margin | - | -226.34% | -18.21% | -485.63% | - |
EBITDA | - | - | -773.65 | -488.13 | - |
EBITDA Margin | - | - | -253.14% | - | - |
D&A For EBITDA | - | - | 8.74 | 8.74 | - |
EBIT | -850.75 | -774.45 | -782.39 | -496.87 | 67 |
EBIT Margin | -115.39% | -114.34% | -256.00% | - | 12.09% |
Effective Tax Rate | - | - | - | - | 1.37% |